These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17531014)

  • 1. Pediatric erosive esophagitis maintenance: finally, some level 1 evidence!
    Orenstein SR
    Am J Gastroenterol; 2007 Jun; 102(6):1298-300. PubMed ID: 17531014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic full-thickness plication (Plicator) with two serially placed implants improves esophagitis and reduces PPI use and esophageal acid exposure.
    von Renteln D; Brey U; Riecken B; Caca K
    Endoscopy; 2008 Mar; 40(3):173-8. PubMed ID: 18322871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-demand therapy is a valid strategy in GERD patients: pros and cons.
    Leodolter A; Penagini R
    Dig Dis; 2007; 25(3):175-8. PubMed ID: 17827935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of endoscopic findings of erosive esophagitis in children: a population-based study.
    Gilger MA; El-Serag HB; Gold BD; Dietrich CL; Tsou V; McDuffie A; Shub MD
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):141-6. PubMed ID: 18664864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving issues in the management of reflux disease?
    Yuan Y; Hunt RH
    Curr Opin Gastroenterol; 2009 Jul; 25(4):342-51. PubMed ID: 19417644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nighttime heartburn in patients with gastroesophageal reflux disease under routine care.
    Nocon M; Labenz J; Jaspersen D; Leodolter A; Meyer-Sabellek W; Stolte M; Vieth M; Lind T; Malfertheiner P; Willich SN
    Digestion; 2008; 77(2):69-72. PubMed ID: 18349541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
    Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnosis of gastroesophageal reflux disease.
    Dughera L; Navino M; Cassolino P; Pellicano R
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):143-52. PubMed ID: 17557042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexlansoprazole (Kapidex) for GERD and erosive esophagitis.
    Med Lett Drugs Ther; 2009 Mar; 51(1308):21-2. PubMed ID: 19305367
    [No Abstract]   [Full Text] [Related]  

  • 11. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
    Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
    Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotherapy and surgery for GERD.
    Triadafilopoulos G
    J Clin Gastroenterol; 2007 Jul; 41 Suppl 2():S87-96. PubMed ID: 17575537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.
    Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J
    Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophageal acid exposure on proton pump inhibitors in unselected asymptomatic gastroesophageal reflux disease patients.
    Grigolon A; Cantù P; Savojardo D; Conte D; Penagini R
    J Clin Gastroenterol; 2008 Oct; 42(9):969-73. PubMed ID: 18719508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group.
    Lee KJ; Kwon HC; Cheong JY; Cho SW
    Digestion; 2009; 79(3):131-6. PubMed ID: 19307735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duodenogastro-esophageal reflux in children with refractory gastro-esophageal reflux disease.
    Hoffman I; Tertychnyy A; Ectors N; De Greef T; Haesendonck N; Tack J
    J Pediatr; 2007 Sep; 151(3):307-11. PubMed ID: 17719945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the latest chemical therapies for reflux esophagitis in children.
    Bardou M; Fortinsky KJ; Chapelle N; Luu M; Barkun A
    Expert Opin Pharmacother; 2019 Feb; 20(2):231-239. PubMed ID: 30496693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retrospective analysis of coexistence of acidic gastroesophageal reflux in children with atopic bronchial asthma].
    Jedynak-Wasowicz U; Przybyszewska K; Szczerbiński T; Cichocka-Jarosz E; Groblicka M; Lis G; Fyderek K
    Przegl Lek; 2007; 64 Suppl 3():115-7. PubMed ID: 18431932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic full-thickness plication for the treatment of GERD by application of multiple Plicator implants: a multicenter study (with video).
    von Renteln D; Schiefke I; Fuchs KH; Raczynski S; Philipper M; Breithaupt W; Caca K; Neuhaus H
    Gastrointest Endosc; 2008 Nov; 68(5):833-44. PubMed ID: 18534586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-cardiac chest pain: the long-term natural history and comparison with gastroesophageal reflux disease.
    Williams JF; Sontag SJ; Schnell T; Leya J
    Am J Gastroenterol; 2009 Sep; 104(9):2145-52. PubMed ID: 19513020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.